Literature DB >> 16311895

MuSK-antibody positive pure ocular myasthenia gravis.

Frank Hanisch, Katharina Eger, Stephan Zierz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16311895     DOI： 10.1007/s00415-005-0032-8

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  12 in total

1.  Anti-MuSK myasthenia gravis presenting with purely ocular findings.

Authors:  James B Caress; Christopher H Hunt; Sat Dev Batish
Journal:  Arch Neurol       Date:  2005-06

2.  Myasthenia gravis: evaluation of treatment in 1,355 patients.

Authors:  V P Perlo; D C Poskanzer; R S Schwab; H R Viets; K E Osserman; G Genkins
Journal:  Neurology       Date:  1966-05       Impact factor: 9.910

3.  Development of generalized disease at 2 years in patients with ocular myasthenia gravis.

Authors:  Mark J Kupersmith; Robert Latkany; Peter Homel
Journal:  Arch Neurol       Date:  2003-02

Review 4.  Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets.

Authors:  Angela Vincent; John Bowen; John Newsom-Davis; John McConville
Journal:  Lancet Neurol       Date:  2003-02       Impact factor: 44.182

5.  Immunotherapy of ocular myasthenia gravis reduces conversion to generalized myasthenia gravis.

Authors:  Jared Mee; Mark Paine; Edward Byrne; John King; Katrina Reardon; Justin O'Day
Journal:  J Neuroophthalmol       Date:  2003-12       Impact factor: 3.042

6.  Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients.

Authors:  Lan Zhou; John McConville; Vinay Chaudhry; Robert N Adams; Richard L Skolasky; Angela Vincent; Daniel B Drachman
Journal:  Muscle Nerve       Date:  2004-07       Impact factor: 3.217

7.  The effect of prednisone on the progression from ocular to generalized myasthenia gravis.

Authors:  Nicholas T Monsul; Huned S Patwa; Amy M Knorr; Robert L Lesser; Jonathan M Goldstein
Journal:  J Neurol Sci       Date:  2004-02-15       Impact factor: 3.181

8.  Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.

Authors:  Amelia Evoli; Pietro A Tonali; Luca Padua; Mauro Lo Monaco; Flavia Scuderi; Anna P Batocchi; Mariapaola Marino; Emanuela Bartoccioni
Journal:  Brain       Date:  2003-06-23       Impact factor: 13.501

9.  Clinical aspects of MuSK antibody positive seronegative MG.

Authors:  D B Sanders; K El-Salem; J M Massey; J McConville; A Vincent
Journal:  Neurology       Date:  2003-06-24       Impact factor: 9.910

10.  Detection and characterization of MuSK antibodies in seronegative myasthenia gravis.

Authors:  John McConville; Maria Elena Farrugia; David Beeson; Uday Kishore; Richard Metcalfe; John Newsom-Davis; Angela Vincent
Journal:  Ann Neurol       Date:  2004-04       Impact factor: 10.422
View more
  5 in total

Review 1.  Anti-MuSK ocular myasthenia with extrinsic ocular muscle atrophy: a new clinical phenotype?

Authors:  Dario Ricciardi; Vincenzo Todisco; Gioacchino Tedeschi; Giovanni Cirillo
Journal:  Neurol Sci       Date:  2019-08-17       Impact factor: 3.307

Review 2.  Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.

Authors:  Michael H Rivner; Mamatha Pasnoor; Mazen M Dimachkie; Richard J Barohn; Lin Mei
Journal:  Neurol Clin       Date:  2018-05       Impact factor: 3.806

3.  Ocular myasthenia gravis: controversies and updates.

Authors:  Sui H Wong; Saif Huda; Angela Vincent; Gordon T Plant
Journal:  Curr Neurol Neurosci Rep       Date:  2014-01       Impact factor: 5.081

4.  Muscle-specific receptor tyrosine kinase antibody positive myasthenia gravis current status.

Authors:  Shin Joong Oh
Journal:  J Clin Neurol       Date:  2009-06-30       Impact factor: 3.077

Review 5.  Update on ocular myasthenia gravis in Taiwan.

Authors:  Chao-Wen Lin; Ta-Ching Chen; Jieh-Ren Jou; Lin-Chung Woung
Journal:  Taiwan J Ophthalmol       Date:  2018 Apr-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.